The new Tempus software analyzes resting, non-ambulatory 12-lead ECG recordings to detect signs associated with having a low ...

The US Food and Drug Administration (FDA) has granted 510(k) clearance for Tempus AI’s ECG-Low (ejection fraction) EF software. This software utilises AI to detect individuals with a low left ...

Tempus AI (TEM) has recently secured FDA clearance for its Tempus ECG-Low EF software, an innovative AI-driven product aiding cardiovascular assessments. This development aligns with TEM’s aim to ...

The team spent 14 months investigating and found that the FDA had allowed more than 150 potentially unsafe drugs in the U.S.

Tempus AI, Inc. (NASDAQ:TEM) saw its stock rise 3% on Wednesday following the announcement that the company obtained 510(k) ...

For instance, "the backlog of FOIAs ... is enormous," he said. Califf said the FDA has far greater opportunities for improved ...

The FDA cleared Rivanna’s SpineNav-AI image processing software and Accuro 3S diagnostic ultrasound system, according to a July 17 news release. SpineNav-AI is a machine-learning software that ...

Real change takes a long time, and when it happens, it must be recognized. The FDA and the NIH have announced their move away ...

Marcel Botha discusses whether AI can truly be used to replace laid off human workers at FDA.

Simulations Plus dipped after Q3 2025 on guidance cuts, but core software strength and long-term growth drivers remain. Find ...

The FDA clears GL-IL2-138, a groundbreaking oral drug modulating natural IL-2, set to revolutionize treatment in oncology.

The FDA has introduced Elsa, an internal AI tool to review safety data, identify labeling issues, and prioritize inspections, ...